Antibiotics

Generic name
Brand names
Common uses[2]
Possible side effects[2]
Mechanism of action
Aminoglycosides
Infections caused by Gram-negative bacteria, such as subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site leaving the bacterium unable to synthesize Ansamycins
Carbacephem
prevents bacterial cell division by inhibiting Carbapenems
Cephalosporins (First generation)
Same mode of action as other beta-lactam • Nausea (if alcohol antibiotics: disrupt the synthesis of the taken concurrently) peptidoglycan layer of bacterial cell walls.
Cephalosporins (Second generation)
Same mode of action as other beta-lactam • Nausea (if alcohol antibiotics: disrupt the synthesis of the taken concurrently) peptidoglycan layer of bacterial cell walls.
Cephalosporins (Third generation)
Same mode of action as other beta-lactam antibiotics: disrupt the synthesis of the peptidoglycan layer of bacterial cell walls.
Cephalosporins (Fourth generation)
Same mode of action as other beta-lactam antibiotics: disrupt the synthesis of the taken concurrently) peptidoglycan layer of bacterial cell walls.
Cephalosporins (Fifth generation)
Same mode of action as other beta-lactam antibiotics: disrupt the synthesis of the taken concurrently) peptidoglycan layer of bacterial cell walls.
Glycopeptides
Lincosamides
Serious staph-, pneumo-, and streptococcal infections in Lipopeptide
Bind to the membrane and cause rapid depolarization, resulting in a loss of membrane potential leading to inhibition of protein, DNA and RNA synthesis Macrolides
inhibition of bacterial protein biosynthesis by binding reversibly to the subunit 50S of the bacterial ribosome, thereby inhibiting Monobactams
Same mode of action as other beta-lactam antibiotics: disrupt the synthesis of the peptidoglycan layer of bacterial cell walls.
Nitrofurans
Penicillins
Same mode of action as other beta-lactam antibiotics: disrupt the synthesis of the peptidoglycan layer of bacterial cell walls.
Penicillin combinations
Polypeptides
Inhibits isoprenyl pyrophosphate, a molecule that carries the building blocks of the peptidoglycan bacterial cell wall outside of the inner membrane [4] Interact with the gram negative bacterial Kidney and nerve damage outer membrane and cytoplasmic membrane. directly to the eye or inhaled (when given by injection) It displaces bacterial counter ions, which destabilizes the outer membrane. They act like a detergent against the cytoplasmic membrane, which alters its permeability. Polymyxin B and E are bactericidal even in an isosmotic solution.
Quinolones
Nausea (rare), irreversible inhibit the bacterial DNA gyrase or the damage to central nervous topoisomerase IV enzyme, thereby inhibiting Sulfonamides
Sulfonamidochrysoidine (archaic) Prontosil catalyses the conversion of PABA (p aminobenzoate) to dihydropteroate, a key step in folate synthesis. Folate is necessary • Decrease in white for the cell to synthesize nucleic acids (nucleic acids are essential building blocks of DNA and RNA), and in its absence cells Tetracyclines
inhibiting the binding of aminoacyl-tRNA to subunit in the mRNA translation complex.
Drugs against mycobacteria
Binds to the β subunit of RNA polymerase to meningitis, MRSA, topical use, or for low cost internal Chloromycetin treatment. Historic: typhus, binding to the 50S subunit of the ribosome cholera. gram negative, gram positive, anaerobes Inactivates enolpyruvyl transferase, thereby Produces toxic free radicals which disrupt mechanism is responsible for its activity amoebiasis, trichomoniasis, nausea ; alcohol is against a variety of bacteria, amoebae, and bacterial protein synthesis by binding to the Generic Name
Brand Names
Common Uses[2]
Possible Side Effects[2]
Mechanism of action

Source: http://www.survivalsyndicate.org/kit/medical/antibiotics.pdf

Microsoft word - t&a aruanne_08_kmi_final.doc

TALLINNA TEHNIKAÜLIKOOL Läbi vaadatud: Kliinilise meditsiini instituudi nõukogus 6.02.2009 ja kinnitatud otsusega nr 1/09 Ruth Sepper 06.02.2009 TEADUS- JA ARENDUSTEGEVUSE AASTAARUANNE 1 KMI üldiseloomustus 1.1 Struktuur ja koosseis Kliinilise Meditsiini Instituut (KMI) loodi 2007. a 23. jaanuaril Tehnomeedikumi instituudina. KMI koosseisu kuulub kaks õppeto

Step therapy criteria

Step Therapy Criteria 2014 MSOFL_Medica Last Updated: 01/01/2014 ANTIDEPRESSANT THERAPY - UHCMR Products Affected Criteria Step 1: One of the following Tier 1 or Tier 2 or Tier 3 antidepressants: SSRI, SNRI, bupropion, mirtazepine. Step 2: Emsam CAMPTOSAR INJECTION THERAPY - UHCMR Products Affected Criteria Step 1: Irinotecan 20 mg/mL injection (generic). Step 2: C

Copyright © 2011-2018 Health Abstracts